Hong Kong announced on Tuesday that it will start administering the Sinovac Biotech coronavirus jab to children aged six months minimum. Previously, the vaccine was approved for three-year-olds, but the decision was made after several younger children contracted COVID-19.
"Recently a series of...
The two-dose vaccine developed by Chinese Sinovac is less effective against the Omicron coronavirus strain compared to other variants even after a booster dose produced by Pfizer and BioNTech, according to the latest study published on Friday.
The research, conducted by multiple institutions...
Three doses of the COVID-19 vaccine developed by Chinese company Sinovac Biotech fail to fully protect against the Omicron coronavirus variant, according to the latest study conducted in Hong Kong and published on Thursday.
However, people who have been inoculated with two Sinovac doses...
China's vaccine manufacturer Sinovac stated on Monday that it can produce a vaccine that targets the latest coronavirus variant, Omicron.
The company noted that the technology and production procedure is the same as for the regular vaccine, thus asserting that the targeted vaccine can be...
Between October 17 and November 5, roughly 918 COVID-19 infections have been confirmed in China causing the country to continue its "dynamic zero COVID" policy, Wu Liangyou, the deputy director from the NHC disease control bureau, said on Saturday.
The new cases confirmed in 44 cities...
The World Health Organization (WHO) recommended on Monday a third COVID-19 dose for people over 60 who received two shots of China's Sinopharm or Sinovac vaccines. Additionally, all moderately or severely immunocompromised individuals should get a third dose, no matter what...
A study conducted by the Malaysian government found that only 0.011% of 7.2 million people vaccinated with the Sinovac shot required intensive care unit treatment for COVID-19, according to health officials.
Despite being higher than the 0.002% and 0.001% recorded for Pfizer and AstraZeneca...
Sinovac Biotech Ltd. announced on Tuesday that the third dose of its COVID-19 vaccine CoronaVac induces a "strong immune response in healthy adults," and added that the booster shot came with "no serious adverse reactions."
The company stated that the "double-blind phase II clinical trial"...
Chilean President Sebastian Pinera announced on Thursday that the country would offer booster shots to all citizens vaccinated with Sinovac's COVID-19 vaccine.
"We have decided to start a reinforcement of the vaccination of those who have already received both doses of the vaccine Sinovac," Pinera...
The Global Alliance for Vaccines and Immunization (GAVI) announced on Monday that it has signed agreements with Chinese vaccine makers Sinovac and Sinopharm, under which they are expected to deliver 550 million COVID-19 vaccine doses to the COVAX program.
"The agreements, which come...
This website uses cookies to ensure you get the best experience. Our Terms of Use and Data Protection Policy explain the data we collect, why we collect them, and how we may share them.
